opioids Archive — Page 6 of 7
-
December 15, 2016
Babies born with opioid withdrawal disproportionately increasing in rural areas
An increasing number of newborns are being born with drug withdrawal symptoms from opioids in rural areas of the United States as compared to births in urban areas, according to a JAMA Pediatrics study. -
October 13, 2016
Drug dependency clinic set to open in Springfield
As Tennessee’s opioid epidemic escalates and the prevalence of opiate dependency in pregnancy continues to require additional resources, Vanderbilt will open another Drug Dependency Clinic at the Vanderbilt Center for Women’s Health at NorthCrest Medical Center in Springfield, Tennessee. -
July 28, 2016
Opioids’ impact on women’s health explored at research symposium
Women may be at higher risk than men when it comes to overuse of opioid-containing painkillers, speakers warned at a research symposium at Vanderbilt University Medical Center earlier this month. -
July 7, 2016
VUMC symposium to explore risks, impact of opioids
The risks of taking opioids during pregnancy or to manage chronic pain, and the impact this frequently prescribed class of pain relievers has on the adolescent brain will be discussed Wednesday, July 13, during a “bedside-to-bench” symposium at Vanderbilt University Medical Center. -
June 23, 2016
Drug monitoring programs reduce opioid deaths: study
The implementation of state prescription drug monitoring programs was associated with the prevention of approximately one opioid-related overdose death every two hours on average nationwide, according to a new Vanderbilt-led study released this week in the journal "Health Affairs." -
June 14, 2016
Study shows opioids increase risk of death when compared to other pain treatments
Long-acting opioids are associated with a significantly increased risk of death when compared with alternative medications for moderate-to-severe chronic pain, according to a Vanderbilt study released today in the Journal of the American Medical Assocation (JAMA). -
May 13, 2016
New pain medicine from a fungus?
Collybolide – a natural product isolated from a mushroom – is a promising candidate for the development of non-addictive pain medicines.